Suven Life Sciences Board of Directors

Get the latest insights into the leadership at Suven Life Sciences. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Venkateswarlu JastiChairman & Managing Director
Seyed E HasnainNon Executive Director
Santanu MukherjeeNon Executive Independent Director
JAS PadmajaNon Executive Independent Director
Vajja Sambasiva RaoNon Executive Independent Director
Sangeetha Laxmi KandariCompany Secretary & Compliance Officer
Sudha Rani JastiWhole Time Director

Suven Life Sciences Share price

SUVEN

202.05

5.61 (-2.70%)
NSE
BSE
Last updated on 24 Apr, 2026 | 15:50 IST
Today's High

209.10

Today's Low

200.25

52 Week Low

120.12

52 Week High

299.99

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Suven Life Sciences FAQs

The board at Suven Life Sciences consists of experienced professionals, including Venkateswarlu Jasti, Seyed E Hasnain, and others, overseeing the company’s strategic and corporate governance.

Directors at Suven Life Sciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Venkateswarlu Jasti is the current chairman at Suven Life Sciences.

Executive directors at Suven Life Sciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Suven Life Sciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Suven Life Sciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost